COMMUNIQUÉS West-GlobeNewswire

-
TYME Provides Business Update and Reports First Quarter Fiscal 2020 Financial and Operating Results
08/08/2019 -
Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15
08/08/2019 -
Aravive Announces Participation at Wedbush PacGrow Healthcare Conference
08/08/2019 -
Dynavax Technologies Announces Pricing of $70.1 Million Public Offering of Common Stock, Non Voting Preferred Stock and Warrants to Purchase Common Stock
08/08/2019 -
Selecta Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update
08/08/2019 -
Progenics Pharmaceuticals Announces Additional Governance Enhancements
08/08/2019 -
Ziopharm Oncology Reports Second Quarter 2019 Financial Results
08/08/2019 -
Autolus Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
08/08/2019 -
Ziopharm Oncology Receives Positive Opinion for Orphan Drug Designation from the European Medicines Agency for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Glioma
08/08/2019 -
Albireo Reports Second Quarter 2019 Financial Results
08/08/2019 -
Atara Biotherapeutics Announces Second Quarter 2019 Financial Results and Recent Operational Progress
08/08/2019 -
Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate Update
08/08/2019 -
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter Financial Results
08/08/2019 -
Agraflora Organics International Inc.
08/08/2019 -
REPEAT - AgraFlora Organics Enters Into Non-Binding CBD Commercialization and Distribution LOI; Commences Discussions With One of Canada’s Largest Food Retailers To Achieve National Branded and Private Label CBD Product Exposure
08/08/2019 -
Recro Pharma Reports Second Quarter 2019 Financial Results
08/08/2019 -
ADMA Biologics Reports Second Quarter and First Half 2019 Financial Results
08/08/2019 -
Orchard Therapeutics Reports Second Quarter 2019 Financial Results and Builds Momentum Ahead of Regulatory Filings
08/08/2019 -
Nabriva Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
08/08/2019
Pages